[1]
M. Payandeh, A. Karami, S. Bavarsad, S. Asadollahi, M. Jafari, and N. Karami, “Anti-PD-1 immune checkpoint blockade-based therapy using pembrolizumab in a patient with high-grade glioblastoma”, BMRAT, vol. 10, no. 5, pp. 5680-5685, May 2023.